Lin Yan, Chen Zhi-Yi, Yang Feng, Zhang Jin-Shan, Wang Yi-Xiang, Liu Jin-Bing, Liao Jian-Yi, Liao Yang-Ying, Zhou Qiu-Lan, Li Bing-Cheng, Liang Hui-Ying
Department of Ultrasound Medicine, Laboratory of Ultrasound Molecular Imaging, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.
Curr Pharm Des. 2015;21(16):2136-46. doi: 10.2174/1381612821666150109122915.
Molecular imaging enables noninvasive characterization, quantification and visualization of biological and pathological processes in vivo at cellular and molecular level. It plays an important role in drug discovery and development. The skillful use of molecular imaging can provide unique insights into disease processes, which greatly aid in identifications of target. Importantly, molecular imaging is widely applied in the pharmacodynamics study to provide earlier endpoints during the preclinical drug development process, since it can be applied to monitor the effects of treatment in vivo with the use of biomarkers. Herein, we reviewed the application of molecular imaging technologies in antitumor drug development process ranging from identification of targets to evaluation of therapeutic effect.
分子成像能够在细胞和分子水平对体内生物和病理过程进行无创性表征、定量分析和可视化。它在药物研发中发挥着重要作用。熟练运用分子成像可提供对疾病过程的独特见解,极大地有助于靶点的识别。重要的是,分子成像广泛应用于药效学研究,以便在临床前药物研发过程中提供更早的终点指标,因为它可利用生物标志物在体内监测治疗效果。在此,我们综述了分子成像技术在抗肿瘤药物研发过程中的应用,范围涵盖从靶点识别到治疗效果评估。